Two anthrax cases with soft tissue infection, severe oedema and sepsis in Danish heroin users

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Russell, Lene ^a   Pedersen, Michael ^a   Jensen, Andreas V ^b   Søes, Lillian Marie ^b   Hansen, Ann Brit Eg ^a  

^a Rigshospitalet   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; HYDROXYCHLOROQUINE; LOW MOLECULAR WEIGHT HEPARIN; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; NORADRENALIN; PENICILLIN DERIVATIVE; PENICILLIN G; RIFAMPICIN; STEROID; TETRACYCLINE; VANCOMYCIN;

ABDOMINAL COMPARTMENT SYNDROME; ABDOMINAL PAIN; ACIDOSIS; ADULT; ANASARCA; ANTHRAX; ANTIBIOTIC SENSITIVITY; ANURIA; ARM SWELLING; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; BACILLUS ANTHRACIS; BLOOD CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS HEMODIAFILTRATION; DEATH; DEEP VEIN THROMBOSIS; DENMARK; DETERIORATION; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; FEVER; FLUID RESUSCITATION; HEPATITIS C; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE; LIVER FAILURE; MALE; METHADONE TREATMENT; MINIMUM INHIBITORY CONCENTRATION; MIXED INFECTION; MULTIPLE ORGAN FAILURE; NONHUMAN; RHABDOMYOLYSIS; SEPSIS; SEPTIC SHOCK; SHOCK; SKIN DISCOLORATION; SOFT TISSUE INFECTION; TACHYCARDIA; VOMITING;

ADULT; ANTHRAX; BACILLUS ANTHRACIS; DENMARK; DRUG CONTAMINATION; EDEMA; HEROIN; HUMANS; MALE; MIDDLE AGED; SEPSIS; SOFT TISSUE INFECTIONS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84883264024     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-408     Document Type: Article

References (20)

1. Hicks CW, Sweeney DA, Cui X, Li Y, Eichacker PQ. An overview of anthrax infection including the recently identified form of disease in injection drug users. Intensive Care Med 2012, 38(7):1092-1104. 10.1007/s00134-012-2541-0, 3523299, 22527064.
2. Ringertz SH, Hoiby EA, Jensenius M, Maehlen J, Caugant DA, Myklebust A, et al. Injectional anthrax in a heroin skin-popper. Lancet 2000, 356(9241):1574-1575. 10.1016/S0140-6736(00)03133-0, 11075776.
3. Ramsay CN, Stirling A, Smith J, Hawkins G, Brooks T, Hood J, et al. An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland. Euro Surveil 2010, 15(2):2-4.
4. Holzmann T, Frangoulidis D, Simon M, Noll P, Schmoldt S, Hanczaruk M, et al. Fatal anthrax infection in a heroin user from southern Germany, June 2012. Euro Surveill 2012, 17(26):2-6.
5. National Anthrax Outbreak Control Team An Outbreak of Anthrax Among Drug Users in Scotland, December 2009 to December 2010. Health Protection Scotland 2011, National Anthrax Outbreak Control Team.
6. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009, 145(1):24-33. 10.1111/j.1365-2141.2009.07600.x, 19222477.
7. Grunow R, Klee SR, Beyer W, George M, Grunow D, Barduhn A, Klar S, Jacob D, Elschner M, Sandven P, Kjerulf A, Jensen JS, Cai W, Zimmermann R, Schaade L. Anthrax among heroin users in Europe possibly caused by same Bacillus anthracis strain since 2000. Euro Surveill 2013, 18(13):2-10.
8. Knox D, Murray G, Millar M, Hamilton D, Connor M, Ferdinand RD, et al. Subcutaneous anthrax in three intravenous drug users: a new clinical diagnosis. J Bone Joint Surg Br 2011, 93(3):414-417.
9. Johns N, Cooper D, Terrace J. An unusual case of peritonitis in an intravenous drug user. Gastroenterology 2011, 141(2):435-438.
10. Powell AGMT, Crozier EMJ, Heather H, Galloway D. A case of septicaemic anthrax in an intravenous drug user. BMC Infect Dis 2011, 11:21. 10.1186/1471-2334-11-21, 3033829, 21251266.
11. Friedlander AM. Tackling anthrax. Nature 2001, 414(6860):160-161. 10.1038/35102660, 11700539.
12. Li Y, Sherer K, Cui X, Eichacker PQ. New insights into the pathogenesis and treatment of anthrax toxin-induced shock. Expert Opin Biol Ther 2007, 7(6):843-854. 10.1517/14712598.7.6.843, 17555370.
13. Moayeri M, Leppla SH. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med 2009, 30(6):439-455. 10.1016/j.mam.2009.07.003, 2784088, 19638283.
14. Lawrence WS, Marshall JR, Zavala DL, Weaver LE, Baze WB, Moen ST, et al. Hemodynamic effects of anthrax toxins in the rabbit model and the cardiac pathology induced by lethal toxin. Toxins (Basel) 2011, 3(6):721-736.
15. Bouzianas DG. Current and future medical approaches to combat the anthrax threat. J Med Chem 2010, 53(11):4305-4331. 10.1021/jm901024b, 20102155.
16. Hirsh MI, Cohen V. Chloroquine prevents T lymphocyte suppression induced by anthrax lethal toxin. J Infect Dis 2006, 194(7):1003-1007. 10.1086/507311, 16960789.
17. Artenstein AW, Opal SM, Cristofaro P, Palardy JE, Parejo NA, Green MD, et al. Chloroquine enhances survival in Bacillus anthracis intoxication. J Infect Dis 2004, 190(9):1655-1660. 10.1086/424853, 15478072.
18. Sherer K, Li Y, Cui X, Li X, Subramanian M, Laird MW, et al. Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model. Crit Care Med 2007, 35(6):1560-1567. 10.1097/01.CCM.0000266535.95770.A2, 17452924.
19. Li Y, Cui X, Su J, Haley M, Macarthur H, Sherer K, et al. Norepinephrine increases blood pressure but not survival with anthrax lethal toxin in rats. Crit Care Med 2009, 37(4):1348-1354. 10.1097/CCM.0b013e31819cee38, 3401929, 19242337.
20. Price EP, Seymour ML, Sarovich DS, Latham J, Wolken SR, Mason J, et al. Molecular epidemiologic investigation of an anthrax outbreak among heroin users. Europe Emerg Infect Dis 2012, 18(8):1307-1313.